Risk of death, hospitalization and intensive care unit admission by SARS-CoV-2 variants in Peru: a retrospective study

https://doi.org/10.1016/j.ijid.2022.12.020Get rights and content
Under a Creative Commons license
open access

HIGHLIGHTS

  • COVID-19 clinical outcomes are significantly related to the SARS-CoV-2 variant.

  • Lambda is the most lethal variant in Peru.

  • High hospitalization rates are associated with the Mu variant.

  • High intensive care unit admission rates are associated with Gamma variants.

ABSTRACT

Objectives

Peru has had the highest death toll from the pandemic worldwide; however, it is not clear what the effects of the different variants on these outcomes are. The study aimed to evaluate the risk of death, hospitalization, and intensive care unit (ICU) admission rates of COVID-19 according to the SARS-CoV-2 variants detected in Peru from March 2020-February 2022.

Methods

Retrospective study using open-access databases were published by the Peruvian Ministry of Health. Databases of genomic sequencing, death, COVID-19 cases, hospitalization and ICU, and vaccination were used. Crude and adjusted Cox proportional hazards regressions with clustered variances were modeled to calculate the hazard ratio (HR) of outcomes by variant.

Results

Lambda variant had the highest risk of death (HR 1.92, 95% CI 1.37-2.68), whereas the Delta variant had the lowest risk (HR 0.50, 95% CI 0.31-0.82). Mu variant had the highest risk of hospitalization (HR: 2.39, 95% CI 1.56-3.67), Omicron the lowest (HR 0.45, 95%CI 0.23-0.90), and Gamma had the highest ICU admission rate (HR 1.95, 95%CI 1.40-2.71).

Conclusion

SARS-CoV-2 variants showed distinctive risks of clinical outcomes, which could have implications for the management of infected persons during the pandemic.

Keywords

SARS-CoV-2 variants
Clinical outcomes
COVID-19
Peru

Cited by (0)